T 0033/19 (Eculizumab for use in treating aHUS/ALEXION) of 22.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T003319.20210422
- Date of decision
- 22 April 2021
- Case number
- T 0033/19
- Online on
- 1 June 2021
- Petition for review of
- -
- Application number
- 15152757.9
- IPC class
- C07K 16/18
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods and compositions for treating complement-associated disorders
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- EPC2000_Art_111(1)_(2007)_Sent_2European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 11Rules of procedure of the Boards of Appeal Art 12(2)
- Keywords
- Sufficiency of disclosure - (yes)
Inventive step - reasonable expectation of success (no)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution.